BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28164560)

  • 1. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
    Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
    Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infection.
    Han M; Li Y; Wu W; Zhang Y; Yan W; Luo X; Ning Q
    Antiviral Res; 2017 Nov; 147():75-85. PubMed ID: 28988797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9.
    Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ
    Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
    Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
    J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
    Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV].
    Zhang Q; Wei L; Wang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):110-3. PubMed ID: 16027772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2
    Xu S; Huang J; Xun Z; Li S; Fu Y; Lin N; Wu W; Chen T; Liu C; Ou Q
    Microbiol Spectr; 2022 Dec; 10(6):e0155722. PubMed ID: 36314949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of HBV and its antigens on the expressions of JAK-STAT signal transduction pathway molecules and antiviral proteins of IFN alpha].
    Guan SH; Yang K; Lu MJ; Lu YP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):440-4. PubMed ID: 22053375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
    Wu S; Lin J; Fu Y; Ou Q
    Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
    Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
    Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
    Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
    Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
    Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
    J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.
    Martin del Campo SE; Levine KM; Mundy-Bosse BL; Grignol VP; Fairchild ET; Campbell AR; Trikha P; Mace TA; Paul BK; Jaime-Ramirez AC; Markowitz J; Kondadasula SV; Guenterberg KD; McClory S; Karpa VI; Pan X; Olencki TE; Monk JP; Mortazavi A; Tridandapani S; Lesinski GB; Byrd JC; Caligiuri MA; Shah MH; Carson WE
    J Immunol; 2015 Sep; 195(5):1995-2005. PubMed ID: 26238487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
    Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA
    Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MxA is a positive regulator of type I IFN signaling in HCV infection.
    Shi X; Jiao B; Chen Y; Li S; Chen L
    J Med Virol; 2017 Dec; 89(12):2173-2180. PubMed ID: 28561372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro immunomodulatory activity of interferon alpha on toll-like receptor 9 signaling pathway in chronic hepatitis B.
    Wang X; Zhao YR; Liu HL; Ma XH; Zhang Y
    J Interferon Cytokine Res; 2015 May; 35(5):385-91. PubMed ID: 25535670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Measles Virus V Protein Binding Site to STAT2 Overlaps That of IRF9.
    Nagano Y; Sugiyama A; Kimoto M; Wakahara T; Noguchi Y; Jiang X; Saijo S; Shimizu N; Yabuno N; Yao M; Gooley PR; Moseley GW; Tadokoro T; Maenaka K; Ose T
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An experimental study on antiviral effects of IFN alpha].
    Lu NF; Huang AL; Tang N; Zheng RQ; Lin H; Zhu YB; Wu Y; Tao P
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):892-6. PubMed ID: 16381632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.